Hamlet Abnousi
Directeur Général chez Abnousi Corporate Finance
Profil
Hamlet Abnousi is the founder of Scitech Global Ventures, Inc. founded in 2012.
He is currently the Chief Executive Officer at Abnousi Corporate Finance since 2007 and at Novobind Livestock Therapeutics, Inc. since 2012.
Mr. Abnousi's former position was as an Independent Director at Millennial Potash Corp.
He received his undergraduate degree from the University of British Columbia in 2000.
Postes actifs de Hamlet Abnousi
Sociétés | Poste | Début |
---|---|---|
Abnousi Corporate Finance | Directeur Général | 01/12/2007 |
Novobind Livestock Therapeutics, Inc.
Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | Directeur Général | 01/10/2012 |
Anciens postes connus de Hamlet Abnousi
Sociétés | Poste | Fin |
---|---|---|
Scitech Global Ventures, Inc. | Fondateur | - |
MILLENNIAL POTASH CORP. | Directeur/Membre du Conseil | - |
Formation de Hamlet Abnousi
University of British Columbia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MILLENNIAL POTASH CORP. | Non-Energy Minerals |
Entreprise privées | 3 |
---|---|
Abnousi Corporate Finance | |
Scitech Global Ventures, Inc. | |
Novobind Livestock Therapeutics, Inc.
Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | Health Technology |